IL-3 or IL-7 increases ex vivo gene transfer efficiency in ADA-SCID BM CD34+ cells while maintaining in vivo lymphoid potential.
暂无分享,去创建一个
M. Roncarolo | C. Bordignon | A. Aiuti | N. Carballido‐Perrig | J. Carballido | A. Colombo | R. J. Hernández | G. Andolfi | F. Ficara | D. Superchi | Cristina Mocchetti | S. Deola
[1] M. Roncarolo,et al. Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice. , 2004, Human gene therapy.
[2] Irving L Weissman,et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. , 2003, Annual review of immunology.
[3] C. Dunbar,et al. Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial. , 2003, Blood.
[4] A. Fischer,et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99 , 2003, The Lancet.
[5] A. Mortellaro,et al. Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning , 2002, Science.
[6] S. Karlsson,et al. Efficient oncoretroviral transduction of extended long-term culture-initiating cells and NOD/SCID repopulating cells: enhanced reconstitution with gene-marked cells through an ex vivo expansion approach. , 2002, Human gene therapy.
[7] L. Notarangelo,et al. Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement , 2002, Nature Medicine.
[8] A. Fischer,et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. , 2002, The New England journal of medicine.
[9] F. Staal,et al. Selective in vitro expansion and efficient retroviral transduction of human CD34+ CD38– haematopoietic stem cells , 2002, British journal of haematology.
[10] M. Roncarolo,et al. A novel human packaging cell line with hematopoietic supportive capacity increases gene transfer into early hematopoietic progenitors. , 2001, Human gene therapy.
[11] T. Nakahata,et al. Inhibitory effect of interleukin 3 on early development of human B‐lymphopoiesis , 2001, British journal of haematology.
[12] D. Nelson,et al. Somatic mosaicism in Wiskott–Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] L. Barsky,et al. Identification of a novel, human multilymphoid progenitor in cord blood. , 2001, Blood.
[14] K. Yamaguchi,et al. T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation. , 2001, Blood.
[15] Y. Hamel,et al. Optimization of retroviral gene transfer protocol to maintain the lymphoid potential of progenitor cells. , 2001, Human gene therapy.
[16] M. Roncarolo,et al. Construction of Human‐SCID Chimeric Mice , 1998, Current protocols in immunology.
[17] W. Piacibello,et al. Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells. , 2000, Journal of hematotherapy & stem cell research.
[18] K Khare,et al. Metabolites from apoptotic thymocytes inhibit thymopoiesis in adenosine deaminase-deficient fetal thymic organ cultures. , 2000, The Journal of clinical investigation.
[19] L. Barsky,et al. IL-3 Increases Production of B Lymphoid Progenitors from Human CD34+CD38− Cells1 , 2000, The Journal of Immunology.
[20] J. Briones,et al. Efficient transduction of human hematopoietic repopulating cells generating stable engraftment of transgene-expressing cells in NOD/SCID mice. , 2000, Blood.
[21] F. Deist,et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. , 2000, Science.
[22] Hiroshi Nakajima,et al. Janus kinase 3 (Jak3) is essential for common cytokine receptor γ chain (γc)-dependent signaling: comparative analysis of γc, Jak3, and γc and Jak3 double-deficient mice , 2000 .
[23] W. Leonard,et al. Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice. , 2000, International immunology.
[24] R. Hoffman,et al. An in vivo competitive repopulation assay for various sources of human hematopoietic stem cells. , 2000, Blood.
[25] J. Nolta,et al. The number and generative capacity of human B lymphocyte progenitors, measured in vitro and in vivo, is higher in umbilical cord blood than in adult or pediatric bone marrow , 1999, Bone Marrow Transplantation.
[26] Michael P. Brown,et al. Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3. , 1999, Blood.
[27] S. Forestell,et al. Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3, and Kit ligands and RetroNectin culture. , 1999, Human gene therapy.
[28] W. Vainchenker,et al. Identification of Lymphomyeloid Primitive Progenitor Cells in Fresh Human Cord Blood and in the Marrow of Nonobese Diabetic–Severe Combined Immunodeficient (NOD-SCID) Mice Transplanted with Human CD34+ Cord Blood Cells , 1999, The Journal of experimental medicine.
[29] K. Moore,et al. Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. , 1999, Blood.
[30] C. Shih,et al. Long-term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells. , 1999, Blood.
[31] Steven F. Ziegler,et al. Defective IL7R expression in T-B+NK + severe combined immunodeficiency , 1998, Nature Genetics.
[32] R. Schiffmann,et al. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. , 1998, Human gene therapy.
[33] F. Hirayama,et al. Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: transduction of the negative signals by betac and betaIL-3 proteins of IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor. , 1998, Blood.
[34] Lesley J. Murray,et al. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone. , 1998, Blood.
[35] I. Weissman,et al. Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.
[36] M. Ogawa,et al. Development of natural killer cells, B lymphocytes, macrophages, and mast cells from single hematopoietic progenitors in culture of murine fetal liver cells. , 1997, Blood.
[37] I. Weissman,et al. Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient Mice , 1997, Cell.
[38] M. Roncarolo,et al. Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver. , 1997, Blood.
[39] J. Liesveld,et al. Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity. , 1997, Blood.
[40] F. Rieux-Laucat,et al. Naturally occurring primary deficiencies of the immune system. , 1997, Annual review of immunology.
[41] T. Lebien,et al. Interleukin 7 independent development of human B cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[42] R. Hoffman,et al. High-level expression of a novel epitope of CD59 identifies a subset of CD34+ bone marrow cells highly enriched for pluripotent stem cells. , 1996, Experimental hematology.
[43] J. Puck,et al. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency , 1996, Nature Genetics.
[44] A. Fischer,et al. Bone marrow gene transfer in three patients with adenosine deaminase deficiency. , 1996, Gene therapy.
[45] F. Hirayama,et al. Negative regulation of early T lymphopoiesis by interleukin-3 and interleukin-1 alpha. , 1995, Blood.
[46] S. Rosenberg,et al. T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years , 1995, Science.
[47] Evelina Mazzolari,et al. Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA− Immunodeficient Patients , 1995, Science.
[48] A. Galy,et al. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. , 1995, Immunity.
[49] K. Weinberg,et al. Engraftment of gene–modified umbilical cord blood cells in neonates with adenosine deaminase deficiency , 1995, Nature Medicine.
[50] A. Nienhuis,et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. , 1995, Blood.
[51] A. Galy,et al. Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice. , 1994, Blood.
[52] R. de Waal Malefyt,et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells , 1994, The Journal of experimental medicine.
[53] S. Nishikawa,et al. Expression and function of the interleukin 7 receptor in murine lymphocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[54] F. Finkelman,et al. Inhibition of murine B and T lymphopoiesis in vivo by an anti- interleukin 7 monoclonal antibody , 1993, The Journal of experimental medicine.
[55] A. Zlotnik,et al. IL-7 maintains the T cell precursor potential of CD3-CD4-CD8- thymocytes. , 1991, Journal of immunology.